Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001999371-25-019650·CureVac N.V.
Schedule 13D ownership disclosure
CUREVAC N V
Common Shares, par value (euro) 0.12 per share · CUSIP: N2451R105
Event date: 2025-12-03
- Filing-level shares
- 0.00
- Percent of class
- 0.00%
- GSK plcReported CIK 0001131399
Shares: 0.00 · Class: 0.00%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001999371-25-019650
- Form type
- SCHEDULE 13D/A
- Filer
- CureVac N.V.
- CIK
- CIK 1809122
- Filed
- Dec 05, 2025
- Reporting period
- Dec 03, 2025
- Description
- Schedule 13D beneficial ownership